PT - JOURNAL ARTICLE AU - Rader, Florian AU - Rashid, Mohamad A. AU - Nguyen, Trevor Trung AU - Luong, Eric AU - Kim, Andy AU - Kim, Elizabeth H. AU - Elashhoff, Robert AU - Davoren, Katherine AU - Moy, Norma B. AU - Nafeh, Fida AU - Bairey Merz, C. Noel AU - Ebinger, Joseph E. AU - Hamburg, Naomi M. AU - Lindner, Jonathan R. AU - Cheng, Susan TI - E-Cigarette Use and Subclinical Cardiac Effects AID - 10.1101/2020.01.16.20017780 DP - 2020 Jan 01 TA - medRxiv PG - 2020.01.16.20017780 4099 - http://medrxiv.org/content/early/2020/01/18/2020.01.16.20017780.short 4100 - http://medrxiv.org/content/early/2020/01/18/2020.01.16.20017780.full AB - BACKGROUND Electronic (e-) cigarettes are marketed as a safer alternative to conventional tobacco cigarettes. Although e-cigarettes contain a lower level of nicotine, the delivery method involves delivering an aerosolized bolus of poorly-characterized ultrafine particles that have unknown cardiovascular effects.METHODS We studied apparently adult volunteers, free of any chronic disease, including: non-smoking controls, chronic e-cigarette users, and chronic tobacco cigarette smokers. After overnight abstinence, we used myocardial contrast echocardiography to measure acute increases in myocardial blood flow (MBF)induced by ischemic rhythmic handgrip stress, which causes sympathetically-mediated increases in myocardial work and oxygen demand and, in turn, shear stress, nitric oxide production, and coronary endothelial-dependent vasodilation.RESULTS In non-smoking controls, handgrip stress increased myocardial blood flow, reflecting normal endothelial function. Chronic tobacco cigarette smokers demonstrated stress-induced blunting in myocardial blood flow change, when compared to non-smoking controls. Chronic e-cigarette smokers demonstrated a decrease, rather than increase, in myocardial blood flow change.CONCLUSION Chronic e-cigarette users demonstrated substantially impaired coronary microvascular endothelial function, even more pronounced than that seen in chronic tobacco cigarette users. These findings suggest that chronic e-cigarette use leads to measurable and persistent adverse vascular effects that are not directly related to nicotine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded in part by an Exploratory/Developmental research grant TRDRP #22XT-0017 from the California Tobacco-Related Disease Research Program, an unrestricted research grant from Gilead Sciences, contracts from the National Heart, Lung and Blood Institutes N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, grants U01-64829, U01-HL649141, U01-HL649241, R01-HL090957, R01-HL134168, R01-HL131532, R01-HL143227, R01-HL078610 and R01-HL130046; and R03AG032631 from the National Institute on Aging, GCRC grant MO1-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences Grant UL1TR000124, the Edythe L. Broad and the Constance Austin Womens Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Womens Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Womens Health Research (SWHR), Washington, D.C., the Linda Joy Pollin Womens Heart Health Program, the Erika Glazer Womens Heart Health Project, and the Adelson Family Foundation, Cedars-Sinai Medical Center, Los Angeles, California.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from Cedars-Sinai Medical Center, upon reasonable request. The data are not publicly available due to the contents including information that could compromise research participant privacy/consent.